Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research whether it be developing next-generation drugs, the next major advancement in agriculture or fuel to move the world...

Press Releases

BIO Statement on Resignation of Peter Marks from the FDA

March 29, 2025

John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary leadership of Dr. Peter Marks, the FDA shepherded in a new era of scientific breakthroughs --…

New survey: U.S. biotechs warn tariffs could impede access to cures, stifle innovation

March 26, 2025

WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global integration of the biomedical supply chain. According to the findings, nearly 90% of U.S. biotech companies rely on imported…

BIO Releases New Report Underscoring the Massive Economic Power of the American Bioeconomy

March 24, 2025

WASHINGTON D.C. – Today, the Biotechnology Innovation Organization (BIO), in partnership with Kearney, a global management consulting firm, released a first-of-its-kind report that assesses the significant economic impact of the U.S. bioeconomy, in the context of plant, animal, and biobased…

BIO Advocacy Toolkit

We’ve made it easier for you to access information and share content about biotechnology and prescription medicines. Learn more about dozens of topics and then share information you discover on Twitter, Facebook, and LinkedIn.

Discover More

Become an Advocate for Biotechnology

Sign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.

Join BIOAction

Human Health

Patient Advocacy

Agriculture & Environment

International

Intellectual Property